Clinical Trials Directory

Trials / Unknown

UnknownNCT05386641

Risk Factors for Shoulder Joint Motion Restriction

Risk Factors for Shoulder Joint Motion Restriction in Breast Cancer Survivors

Status
Unknown
Phase
Study type
Observational
Enrollment
72 (estimated)
Sponsor
Istanbul Medeniyet University · Academic / Other
Sex
Female
Age
30 Years – 60 Years
Healthy volunteers
Not accepted

Summary

In breast cancer patients, limitation of shoulder joint movement may occur following cancer treatment. Shoulder limitation causes a significant decrease in the patient's participation in activities of daily living. The aim of the study is to define these limitations, to evaluate in detail all the structures that cause the problem, and to determine the causes of the limitations in patients with shoulder joint movement limitation developed after breast cancer survivors.

Conditions

Interventions

TypeNameDescription
OTHERmeasurement of tissue stiffness (N/m)Stiffness values will be measured with myotonPro on centers of coordination located along the myofascial chain
OTHERmeasurement of passive muscle tone (Hz)muscle tones will be measured with myotonPro on centers of coordination located along along the myofascial chain
OTHERmeasurement of creep of tissuecreep of tissue will be measured with myotonPro on centers of coordination located along the myofascial chain
OTHERmeasurement of the range of shoulder joint motionThe range of shoulder flexion, abduction, extension and external-internal rotation movements will be measured with a universal goniometer.
OTHERmeasurement of skin temperaturemeasurements will be taken by the thermographic camera
OTHERmeasurement of painPain will be evaluated by visual analog scale (VAS)
OTHERmeasurement of pain pressure thresholdPain pressure threshold will be evaluated by a digital algometer
OTHERmeasurement of grip strengthThe grip strength of both hand will be evaluated by "hand-held" dynamometer.

Timeline

Start date
2022-08-15
Primary completion
2023-08-15
Completion
2024-02-15
First posted
2022-05-23
Last updated
2022-05-31

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT05386641. Inclusion in this directory is not an endorsement.